カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

非侵襲的薬物送達デバイスの世界市場2022：液体系無針注射器、粉末系無針注射器

◆英語タイトル：Global Non-Invasive Drug Delivery Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO18100 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：104 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

非侵襲的薬物送達デバイス市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の非侵襲的薬物送達デバイスの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

非侵襲的薬物送達デバイス市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・液体系無針注射器、粉末系無針注射器

用途別セグメントは次のように区分されます。
・糖尿病管理、ワクチン管理、疼痛管理、呼吸管理、その他

世界の非侵襲的薬物送達デバイス市場の主要な市場プレーヤーは以下のとおりです。
・Novartis AG、Inovio Pharmaceuticals, Inc.、Medtronic Plc.、Tandem Diabetes Care, Inc.、Teva Pharmaceutical Industries Ltd.、Crossject Medical Technology、Adherium Ltd.、Sensirion AG、Diabeloop、PharmaJet、PenJet、Portal Instruments、Capsule Technologies、Propeller Health

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、非侵襲的薬物送達デバイス製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な非侵襲的薬物送達デバイスメーカーの企業概要、2019年～2022年までの非侵襲的薬物送達デバイスの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な非侵襲的薬物送達デバイスメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別非侵襲的薬物送達デバイスの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの非侵襲的薬物送達デバイスの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での非侵襲的薬物送達デバイス市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および非侵襲的薬物送達デバイスの産業チェーンを掲載しています。
・第13、14、15章では、非侵襲的薬物送達デバイスの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 非侵襲的薬物送達デバイスの概要
- 種類別分析（2017年vs2021年vs2028年）：液体系無針注射器、粉末系無針注射器
- 用途別分析（2017年vs2021年vs2028年）：糖尿病管理、ワクチン管理、疼痛管理、呼吸管理、その他
- 世界の非侵襲的薬物送達デバイス市場規模・予測
- 世界の非侵襲的薬物送達デバイス生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Novartis AG、Inovio Pharmaceuticals, Inc.、Medtronic Plc.、Tandem Diabetes Care, Inc.、Teva Pharmaceutical Industries Ltd.、Crossject Medical Technology、Adherium Ltd.、Sensirion AG、Diabeloop、PharmaJet、PenJet、Portal Instruments、Capsule Technologies、Propeller Health
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：液体系無針注射器、粉末系無針注射器
・用途別分析2017年-2028年：糖尿病管理、ワクチン管理、疼痛管理、呼吸管理、その他
・非侵襲的薬物送達デバイスの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・非侵襲的薬物送達デバイスのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・非侵襲的薬物送達デバイスのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・非侵襲的薬物送達デバイスの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・非侵襲的薬物送達デバイスの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Non-Invasive Drug Delivery Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Non-Invasive Drug Delivery Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Diabetes Management accounting for % of the Non-Invasive Drug Delivery Device global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Liquid-Based Needle-Free Injector segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Non-Invasive Drug Delivery Device include Novartis AG, Inovio Pharmaceuticals, Inc., Medtronic Plc., Tandem Diabetes Care, Inc., and Teva Pharmaceutical Industries Ltd., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Non-Invasive Drug Delivery Device market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liquid-Based Needle-Free Injector
Powder-Based Needle-Free Injector
Market segment by Application can be divided into
Diabetes Management
Vaccine Management
Pain Management
Respiratory Management
Others
The key market players for global Non-Invasive Drug Delivery Device market are listed below:
Novartis AG
Inovio Pharmaceuticals, Inc.
Medtronic Plc.
Tandem Diabetes Care, Inc.
Teva Pharmaceutical Industries Ltd.
Crossject Medical Technology
Adherium Ltd.
Sensirion AG
Diabeloop
PharmaJet
PenJet
Portal Instruments
Capsule Technologies
Propeller Health
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-Invasive Drug Delivery Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-Invasive Drug Delivery Device, with price, sales, revenue and global market share of Non-Invasive Drug Delivery Device from 2019 to 2022.
Chapter 3, the Non-Invasive Drug Delivery Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Invasive Drug Delivery Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Non-Invasive Drug Delivery Device market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Drug Delivery Device.
Chapter 13, 14, and 15, to describe Non-Invasive Drug Delivery Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Non-Invasive Drug Delivery Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-Invasive Drug Delivery Device Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Liquid-Based Needle-Free Injector
1.2.3 Powder-Based Needle-Free Injector
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-Invasive Drug Delivery Device Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diabetes Management
1.3.3 Vaccine Management
1.3.4 Pain Management
1.3.5 Respiratory Management
1.3.6 Others
1.4 Global Non-Invasive Drug Delivery Device Market Size & Forecast
1.4.1 Global Non-Invasive Drug Delivery Device Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Non-Invasive Drug Delivery Device Sales in Volume (2017-2028)
1.4.3 Global Non-Invasive Drug Delivery Device Price (2017-2028)
1.5 Global Non-Invasive Drug Delivery Device Production Capacity Analysis
1.5.1 Global Non-Invasive Drug Delivery Device Total Production Capacity (2017-2028)
1.5.2 Global Non-Invasive Drug Delivery Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-Invasive Drug Delivery Device Market Drivers
1.6.2 Non-Invasive Drug Delivery Device Market Restraints
1.6.3 Non-Invasive Drug Delivery Device Trends Analysis
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Non-Invasive Drug Delivery Device Product and Services
2.1.4 Novartis AG Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Inovio Pharmaceuticals, Inc.
2.2.1 Inovio Pharmaceuticals, Inc. Details
2.2.2 Inovio Pharmaceuticals, Inc. Major Business
2.2.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Device Product and Services
2.2.4 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Medtronic Plc.
2.3.1 Medtronic Plc. Details
2.3.2 Medtronic Plc. Major Business
2.3.3 Medtronic Plc. Non-Invasive Drug Delivery Device Product and Services
2.3.4 Medtronic Plc. Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Tandem Diabetes Care, Inc.
2.4.1 Tandem Diabetes Care, Inc. Details
2.4.2 Tandem Diabetes Care, Inc. Major Business
2.4.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Device Product and Services
2.4.4 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Teva Pharmaceutical Industries Ltd.
2.5.1 Teva Pharmaceutical Industries Ltd. Details
2.5.2 Teva Pharmaceutical Industries Ltd. Major Business
2.5.3 Teva Pharmaceutical Industries Ltd. Non-Invasive Drug Delivery Device Product and Services
2.5.4 Teva Pharmaceutical Industries Ltd. Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Crossject Medical Technology
2.6.1 Crossject Medical Technology Details
2.6.2 Crossject Medical Technology Major Business
2.6.3 Crossject Medical Technology Non-Invasive Drug Delivery Device Product and Services
2.6.4 Crossject Medical Technology Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Adherium Ltd.
2.7.1 Adherium Ltd. Details
2.7.2 Adherium Ltd. Major Business
2.7.3 Adherium Ltd. Non-Invasive Drug Delivery Device Product and Services
2.7.4 Adherium Ltd. Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sensirion AG
2.8.1 Sensirion AG Details
2.8.2 Sensirion AG Major Business
2.8.3 Sensirion AG Non-Invasive Drug Delivery Device Product and Services
2.8.4 Sensirion AG Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Diabeloop
2.9.1 Diabeloop Details
2.9.2 Diabeloop Major Business
2.9.3 Diabeloop Non-Invasive Drug Delivery Device Product and Services
2.9.4 Diabeloop Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 PharmaJet
2.10.1 PharmaJet Details
2.10.2 PharmaJet Major Business
2.10.3 PharmaJet Non-Invasive Drug Delivery Device Product and Services
2.10.4 PharmaJet Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 PenJet
2.11.1 PenJet Details
2.11.2 PenJet Major Business
2.11.3 PenJet Non-Invasive Drug Delivery Device Product and Services
2.11.4 PenJet Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Portal Instruments
2.12.1 Portal Instruments Details
2.12.2 Portal Instruments Major Business
2.12.3 Portal Instruments Non-Invasive Drug Delivery Device Product and Services
2.12.4 Portal Instruments Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Capsule Technologies
2.13.1 Capsule Technologies Details
2.13.2 Capsule Technologies Major Business
2.13.3 Capsule Technologies Non-Invasive Drug Delivery Device Product and Services
2.13.4 Capsule Technologies Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Propeller Health
2.14.1 Propeller Health Details
2.14.2 Propeller Health Major Business
2.14.3 Propeller Health Non-Invasive Drug Delivery Device Product and Services
2.14.4 Propeller Health Non-Invasive Drug Delivery Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Non-Invasive Drug Delivery Device Breakdown Data by Manufacturer
3.1 Global Non-Invasive Drug Delivery Device Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Non-Invasive Drug Delivery Device Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Non-Invasive Drug Delivery Device
3.4 Market Concentration Rate
3.4.1 Top 3 Non-Invasive Drug Delivery Device Manufacturer Market Share in 2021
3.4.2 Top 6 Non-Invasive Drug Delivery Device Manufacturer Market Share in 2021
3.5 Global Non-Invasive Drug Delivery Device Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Non-Invasive Drug Delivery Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Non-Invasive Drug Delivery Device Market Size by Region
4.1.1 Global Non-Invasive Drug Delivery Device Sales in Volume by Region (2017-2028)
4.1.2 Global Non-Invasive Drug Delivery Device Revenue by Region (2017-2028)
4.2 North America Non-Invasive Drug Delivery Device Revenue (2017-2028)
4.3 Europe Non-Invasive Drug Delivery Device Revenue (2017-2028)
4.4 Asia-Pacific Non-Invasive Drug Delivery Device Revenue (2017-2028)
4.5 South America Non-Invasive Drug Delivery Device Revenue (2017-2028)
4.6 Middle East and Africa Non-Invasive Drug Delivery Device Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Non-Invasive Drug Delivery Device Sales in Volume by Type (2017-2028)
5.2 Global Non-Invasive Drug Delivery Device Revenue by Type (2017-2028)
5.3 Global Non-Invasive Drug Delivery Device Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Non-Invasive Drug Delivery Device Sales in Volume by Application (2017-2028)
6.2 Global Non-Invasive Drug Delivery Device Revenue by Application (2017-2028)
6.3 Global Non-Invasive Drug Delivery Device Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Non-Invasive Drug Delivery Device Sales by Type (2017-2028)
7.2 North America Non-Invasive Drug Delivery Device Sales by Application (2017-2028)
7.3 North America Non-Invasive Drug Delivery Device Market Size by Country
7.3.1 North America Non-Invasive Drug Delivery Device Sales in Volume by Country (2017-2028)
7.3.2 North America Non-Invasive Drug Delivery Device Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Non-Invasive Drug Delivery Device Sales by Type (2017-2028)
8.2 Europe Non-Invasive Drug Delivery Device Sales by Application (2017-2028)
8.3 Europe Non-Invasive Drug Delivery Device Market Size by Country
8.3.1 Europe Non-Invasive Drug Delivery Device Sales in Volume by Country (2017-2028)
8.3.2 Europe Non-Invasive Drug Delivery Device Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Non-Invasive Drug Delivery Device Sales by Type (2017-2028)
9.2 Asia-Pacific Non-Invasive Drug Delivery Device Sales by Application (2017-2028)
9.3 Asia-Pacific Non-Invasive Drug Delivery Device Market Size by Region
9.3.1 Asia-Pacific Non-Invasive Drug Delivery Device Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Non-Invasive Drug Delivery Device Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Non-Invasive Drug Delivery Device Sales by Type (2017-2028)
10.2 South America Non-Invasive Drug Delivery Device Sales by Application (2017-2028)
10.3 South America Non-Invasive Drug Delivery Device Market Size by Country
10.3.1 South America Non-Invasive Drug Delivery Device Sales in Volume by Country (2017-2028)
10.3.2 South America Non-Invasive Drug Delivery Device Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Non-Invasive Drug Delivery Device Sales by Type (2017-2028)
11.2 Middle East & Africa Non-Invasive Drug Delivery Device Sales by Application (2017-2028)
11.3 Middle East & Africa Non-Invasive Drug Delivery Device Market Size by Country
11.3.1 Middle East & Africa Non-Invasive Drug Delivery Device Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Non-Invasive Drug Delivery Device Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Non-Invasive Drug Delivery Device and Key Manufacturers
12.2 Manufacturing Costs Percentage of Non-Invasive Drug Delivery Device
12.3 Non-Invasive Drug Delivery Device Production Process
12.4 Non-Invasive Drug Delivery Device Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Non-Invasive Drug Delivery Device Typical Distributors
13.3 Non-Invasive Drug Delivery Device Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 非侵襲的薬物送達デバイスの世界市場2022：液体系無針注射器、粉末系無針注射器(Global Non-Invasive Drug Delivery Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

非侵襲的薬物送達デバイスの世界市場2022：液体系無針注射器、粉末系無針注射器

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp